PADI2 and posterior cortical atrophy: This treatment strategy may potentially be used to a subset of CRPC patients with PADI2 expression, but further investigations are needed to evaluate whether PADI2 inhibition could be a preventive strategy for PCa progression especially in CRPC patients (Wang et al., 2017).